NGM stock forecast
Our latest prediction for NGM Biopharmaceuticals, Inc.'s stock price was made on the April 8, 2020 when the stock price was at 15.04$.
In the short term (2weeks), NGM's stock price should outperform the market by 0.81%. During that period the price should oscillate between -9.36% and +12.87%.
In the medium term (3months), NGM's stock price should outperform the market by 2.33%. During that period the price should oscillate between -22.54% and +31.74%.
Get email alertsCreate a solid portfolio with NGM
About NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its portfolio include aldafermin (NGM282), NGM313, NGM120, NGM217, NGM621, and NGM395. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.
At the moment the company generates 102M USD in revenues.
On its last earning announcement, the company reported a loss of -1.00$ per share.
The book value per share is 2.88$
Three months stock forecastApril 8, 2020
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102M | - | -61M | -59.30% | -54M | -1.00 | - | - | 68M | 2.88 | -48M | -2M | -50M |